Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MPC vs MRNA✓SelectedUSD · MRNAMPC vs MRNA performance historyLatest closeAs of-1.59%11/19
Stock and ETF performance explorer

MPC vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+161.3%
MRNA return
+159.5%
Excess return
+1.7%
Maximum drawdown
-44.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.6%+1.3%-2.9%-1.6%
7D-10.6%-13.8%+3.2%-10.6%
30D-22.3%-17.7%-4.7%-22.3%
3M+2.3%+14.3%-12.0%+2.2%
6M+41.2%+336.0%-294.8%+37.0%
YTD+129.5%+575.9%-446.4%+115.5%
1Y+90.9%+724.4%-633.5%+76.5%
All+161.3%+159.5%+1.7%+138.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling